A pharmaceutical industry consultant helps you pick the right plant, size it correctly and meet regulatory requirements before you invest. NPCS covers formulation plants, surgical dressings, medical devices and hygiene products. Most clients here are first-time manufacturers, existing traders moving into production and investors looking at contract manufacturing or exports. Our team prepares the project report, advises on technology and machinery, and supports your approvals and finance planning, so your decision rests on working numbers rather than guesses.
Pharmaceutical Industry Business Ideas in India
Pharmaceutical industry business ideas in India draw on three demand drivers: healthcare expansion, contract manufacturing and exports. Each one supports a different kind of plant. A formulation unit can serve own brands, third-party clients or export buyers, while device and dressing plants sell mainly to hospitals and retail.
The sub-sectors NPCS advises on are listed here.
Main buyer groups
- Tablet, capsule and liquid formulations
- Surgical cotton and bandages
- Disposable syringes
- Sanitary napkins
Projects We Advise On
Sanitary Napkin Plant
Disposable menstrual pads with an absorbent core (fluff pulp and super-absorbent polymer) between a non-woven top sheet and a leak-proof back sheet; biodegradable versions use plant fibres.
- Main buyers
- Distributors, chemists, modern trade, e-commerce, government tenders, CSR buyers
- Typical capacity
- ~2,000 pads/day (semi-auto) to several lakh pads/day (automatic line)
Pharmaceutical Formulation Plant
Converting active ingredients and excipients into tablets, capsules, syrups, ointments and powders under revised Schedule M GMP, for own brands, third-party clients or export.
- Main buyers
- Pharma marketing companies, distributors, government tenders (Jan Aushadhi, state medical corporations), export buyers
- Typical capacity
- Line-dependent, e.g. tens of crores of tablets per year per line
Surgical Cotton and Bandage Plant
Turning raw cotton into absorbent surgical cotton wool and processing gauze into bandages, swabs and dressings for hospitals and retail.
- Main buyers
- Hospitals, government tenders, pharma distributors, first-aid kit makers
- Typical capacity
- ~1–10 TPD
Disposable Syringe Plant
Moulding syringe barrels and plungers, assembling them with gaskets and needles, printing scales, and sterilising and packing them as single-use medical devices, including auto-disable syringes.
- Main buyers
- Hospitals, state medical corporations and tenders, national immunisation programme (auto-disable syringes), distributors, exporters
- Typical capacity
- ~50 lakh to several crore units per year
Planning a Different Pharmaceutical Industry Project?
These are a few of the projects we advise on. NPCS's published client list records 97 pharmaceuticals and healthcare assignments, so tell us what you are planning.
How to Choose the Right Pharmaceutical Industry Project
Start by comparing regulation, raw material and buyer type, because these differ sharply between projects. A pharmaceutical formulation plant works under revised Schedule M GMP and suits those targeting brands, contract work or export. A disposable syringe plant is a medical device project built on moulding, assembly and sterilisation. Surgical cotton and bandages turn raw cotton and gauze into hospital and retail products, and sanitary napkins serve a consumer hygiene market. Share your budget and buyers, and we'll narrow the options.
| Project | Main inputs | Indicative investment | Power load |
|---|---|---|---|
| Sanitary Napkin Plant | Fluff pulp, SAP, non-woven top sheet, PE or breathable back sheet, release paper, hot-melt adhesive, wrappers and packaging | ~₹10 lakh–₹1 crore (semi-auto); ~₹3–10 crore (automatic line) | ~20–250 kW |
| Pharmaceutical Formulation Plant | APIs, excipients, coating materials, capsule shells, blister foil, PVC/PVDC film, bottles, cartons | ~₹15–100 crore (Schedule M compliant; export GMP higher) | ~300 kW–2 MW (HVAC-heavy) |
| Surgical Cotton and Bandage Plant | Raw cotton or comber noil, scouring and bleaching chemicals, grey gauze/yarn, elastic yarn (crepe), packaging | ~₹3–20 crore | ~150–600 kW |
| Disposable Syringe Plant | Medical-grade polypropylene, rubber/TPE gaskets, stainless-steel cannula, silicone oil, adhesive, ink, blister/paper packaging, EtO gas | ~₹10–100 crore | ~300 kW–2 MW |
Common Licences for Pharmaceutical Industry Projects
Drug manufacturing needs licences under the Drugs and Cosmetics Act, along with revised Schedule M GMP compliance. Medical devices fall under the Medical Devices Rules, 2017. Exporters usually need WHO-GMP, and price-controlled medicines bring DPCO and NPPA compliance. Pollution category depends on the activity: formulation is Orange (S.No. 123.3), while assembly-only medical products are often White or Green. Plan these approvals before you order machinery.
Approvals Common to Pharmaceutical Industry Plants
- Drug manufacturing licences under the Drugs and Cosmetics Act
- Revised Schedule M GMP
- Medical Devices Rules, 2017
- WHO-GMP for exports
- DPCO/NPPA compliance
Pollution Category by Project (CPCB, January 2025)
- Sanitary Napkin Plant
- Units limited to stitching or assembly are White in several state lists (e.g. Assam PCB, 2025); automated pad-making lines are dry converting with no effluent and are generally White or Green. The State PCB fixes the category at consent stage
- Pharmaceutical Formulation Plant
- Pharmaceutical formulation: Orange (CPCB Jan-2025 Annexure-I S.No. 123.3; 123.4 on cleaner fuel)
- Surgical Cotton and Bandage Plant
- Units bleaching cotton (with effluent) are generally Orange; converting bought bleached cotton and gauze without effluent is generally Green or White (several state White lists include assembly-only medical products)
- Disposable Syringe Plant
- Moulding and assembly is closest to plastic processed products (CPCB S.No. 132, Green); state White lists include 'surgical and medical products assembled only'; in-house EtO sterilisation (a hazardous air pollutant) raises the category to Orange or above
Schemes and Regulatory Changes in the Pharmaceutical Industry
Revised Schedule M now applies to all manufacturers, including MSMEs, so even small units must plan for it. GST on most medicines and medical devices was cut to 5% in September 2025. Support options include the revamped Pharmaceutical Technology Upgradation Assistance Scheme, medical device parks and Jan Aushadhi procurement. Eligibility depends on each scheme's current terms, so confirm them before you apply.
Schemes and Incentives
- Revamped Pharmaceutical Technology Upgradation Assistance Scheme
- Medical device parks
- Jan Aushadhi procurement
Policy Changes to Track
- Revised Schedule M now applies to all manufacturers including MSMEs
- GST on most medicines and medical devices cut to 5% (Sept 2025)
How NPCS Works as Your Pharmaceutical Industry Project Consultant
As a pharmaceutical industry project consultant, NPCS ties its services to your real decisions. We prepare the pharmaceutical industry project report, covering feasibility, market research and finance. We also support machinery selection, vendor selection, plant layout, process guidance, and installation and commissioning assistance. Reports are used for bank loans and programmes such as PMEGP, MSME schemes, Mudra and NABARD-linked projects, subject to each lender's requirements.
NPCS's published client list records 97 assignments across pharmaceuticals and healthcare projects between 2011 and 2026, for clients in 23 states and 17 countries.
Pharmaceutical Industry organisations that appear in NPCS's published client list:
GSK, Dabur, Sunil Healthcare, Nureca.
What Your Pharmaceutical Industry Project Report Covers
- Project introduction and BIS specifications
- Manufacturing process with flow sheet
- Market survey (demand, imports/exports, existing units)
- Personnel
- Plant and machinery with suppliers
- Land and building with layout
- Raw materials with sources and rates
- Financials (project cost, working capital, cost of production, profitability, break-even, 5–10 year cash flow, projected balance sheet, IRR/NPV/payback)
Pharmaceutical Industry: Frequently Asked Questions
Which pharmaceutical industry project should I start first?
It depends on your budget, technical background and target buyers. Formulation suits brand, contract or export plans, while syringes, surgical cotton and sanitary napkins suit device, dressing or hygiene markets. Share your budget and location, and our team will compare the options.
What licences are needed for a pharmaceutical plant?
Drug manufacturing needs licences under the Drugs and Cosmetics Act and compliance with revised Schedule M GMP. Medical devices follow the Medical Devices Rules, 2017. Exports usually need WHO-GMP. Your project report sets out the order of approvals for your product.
What is the pollution category for pharmaceutical projects?
Formulation is Orange under S.No. 123.3. Assembly-only medical products are often White or Green, depending on the process. Your State Pollution Control Board confirms the final category, so check it before you finalise the site and layout.
Does revised Schedule M apply to small manufacturers?
Yes. Revised Schedule M now applies to all manufacturers, including MSMEs. A small formulation unit should therefore plan its premises, equipment and quality systems to GMP standards from the start, and your project report can reflect those costs.
How does NPCS help with a pharmaceutical project?
NPCS prepares detailed project reports, feasibility studies and market research, and supports machinery selection, vendor selection and plant layout. Our team also guides process, installation and commissioning. Talk to us about your capacity and location, and we'll outline the next steps.